Literature DB >> 7541413

Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma.

I Angulo1, R Rodríguez, B García, M Medina, J Navarro, J L Subiza.   

Abstract

Bone marrow (BM)-derived natural suppressor (NS) cells are strong inhibitors of lymphoproliferative responses. In this study we have assessed the involvement of nitric oxide (NO) in BM-derived NS activity, as detected in cocultures of BM and spleen cells stimulated with B cell (LPS) or T cell (Con A) mitogens. The results indicate that NS activity is readily inhibited by NG-monomethyl-L-arginine, a competitive inhibitor of NO synthase, or N-acetylcysteine, a free radical-scavenging thiol compound. High amounts of nitrite, a stable end product of NO, are detected only in supernatants of Con A- or LPS-stimulated spleen cells cocultured with BM cells enriched in NS activity (Fr3 cells). These amounts (15 to 55 microM) are strongly antiproliferative for both Con A and LPS responses, as was established with a nitrite curve made with a NO donor (sodium nitroprusside). Fr3 cells cultured alone release large quantities of NO and express inducible NO synthase (iNOS) mRNA upon LPS stimulation, but require spleen cells in cultures stimulated with Con A. Anti-IFN-gamma-neutralizing Abs blocked both NO production and NS activity, irrespective of the mitogen used; yet, only exogenous IFN-gamma is unable to promote successful NO production by Fr3 cells, but does induce detectable iNOS mRNA expression in these cells. Taken together the results indicate that: 1) NO is the major mediator of BM-derived NS activity; 2) BM cells enriched in NS activity produce large amounts of NO through an IFN-gamma-dependent iNOS induction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541413

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

Review 2.  Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Authors:  Sabrin Husein Albeituni; Chuanlin Ding; Jun Yan
Journal:  Cancer J       Date:  2013 Nov-Dec       Impact factor: 3.360

3.  Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.

Authors:  Jessica L Rastad; William R Green
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

4.  The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth.

Authors:  Nikolai Nikolaevich Belyaev; Andrei-Yurievich Bogdanov; Philipp-Georgievich Savvulidi; Vladimir-Konstantinovich Krasnoshtanov; Raikhan-Tleulievna Tleulieva; Gabit-Kaimovich Alipov; Ichiro Sekine; Jun-Sang Bae; Jeong-Beom Lee; Young-Ki Min; Hun-Mo Yang
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

5.  In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.

Authors:  Andrew J Ditto; John J Reho; Kush N Shah; Justin A Smolen; James H Holda; Rolando J Ramirez; Yang H Yun
Journal:  Mol Pharm       Date:  2013-04-08       Impact factor: 4.939

6.  Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Authors:  Minu K Srivastava; Li Zhu; Marni Harris-White; Upendra K Kar; Upendra Kar; Min Huang; Ming F Johnson; Jay M Lee; David Elashoff; Robert Strieter; Steven Dubinett; Sherven Sharma
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

7.  Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections.

Authors:  Takayuki Matsumura; Manabu Ato; Tadayoshi Ikebe; Makoto Ohnishi; Haruo Watanabe; Kazuo Kobayashi
Journal:  Nat Commun       Date:  2012-02-14       Impact factor: 14.919

8.  IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.

Authors:  Martin Rottman; Claire Soudais; Guillaume Vogt; Laurent Renia; Jean-François Emile; Hélène Decaluwe; Jean-Louis Gaillard; Jean-Laurent Casanova
Journal:  PLoS Med       Date:  2008-01-29       Impact factor: 11.069

9.  Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy.

Authors:  Wei He; Pei Liang; Guangxing Guo; Zhen Huang; Yiming Niu; Lei Dong; Chunming Wang; Junfeng Zhang
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.